Levosimendan Intermediate CAS 36725-28-7 Ịdị Ọcha> Ụlọ ọrụ 99.5% (HPLC)
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 6-(4-Aminophenyl)-4,5-Dihydro-5-Methyl-3(2H)-Pyridazinone (CAS: 36725-28-7) with high quality, commercial production. We can provide COA, worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com
Aha Chemical | 6- (4-Aminophenyl) -4,5-Dihydro-5-Methyl-3 (2H) -Pyridazinone |
Ụdị okwu | 6- (p-Aminophenyl) -5-methyl-4,5-dihydro-3 (2H) -pyridazinone;1,4-Dihydro-4-Methyl-3- (4-Aminophenyl) pyridazine-6 (5H) -otu;Levosimendan adịghị ọcha 5 |
Nọmba CAS | 36725-28-7 |
Nọmba CAT | RF-PI1976 |
Ọnọdụ Ahịa | N'ọkwa, Mpụta Ihe ruru Tọn |
Usoro ihe omimi | C11H13N3O |
Ibu molekụla | 203.25 |
Ebe Na-agbaze | 194.0 ruo 198.0 ℃ |
Njupụta | 1.30±0.10 g/cm3 |
Ụdị | Ruifu Chemical |
Ihe | Nkọwapụta |
Ọdịdị | Gbanyụọ-Ọcha ka ntụ ntụ ntụ ntụ na-acha odo odo |
njirimara (HPLC) | HPLC RT nke isi kacha elu dabara na nke ọkọlọtọ arụ ọrụ n'ime ụlọ |
Ọnwụ na ihicha | <0.50% |
Ihe fọdụrụ na mgbanye | <0.20% |
Ihe ndị emetụtara | (HPLC) |
Otu adịghị ọcha | <0.20% |
Mgbakọta adịghị ọcha | <0.50% |
Ụzọ ịdị ọcha / nyocha | > 99.5% (HPLC) |
Ọla dị arọ | <20ppm |
Ọnụ ego nke Proton NMR Spectrum | Dabara na Ọdịdị |
Nlele ọkọlọtọ | Standardkpụrụ ụlọ ọrụ |
Ojiji | Ọkara nke Levosimendan (CAS: 141505-33-1) |
ngwugwu: Kalama, Aluminom foil bag, 25kg / Cardboard Drum, ma ọ bụ dị ka ndị ahịa chọrọ
Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè na mmiri mmiri
6- (4-Aminophenyl) -4,5-Dihydro-5-Methyl-3 (2H) -Pyridazinone (CAS: 36725-28-7) bụ etiti nke Levosimendan (CAS: 141505-33-1).Ewebatara Levosimendan na Sweden dị ka infusion iv maka ọgwụgwọ nnukwu nkụda obi ma ọ bụ mgbaama mgbagha nke nkụda mmụọ na-adịghị ala ala n'ọnọdụ ebe ọgwụgwọ ọdịnala (dịka ọmụmaatụ, diuretic ma ọ bụ ACE inhibitor) ezughi oke.Ọ na-arụkwa ọrụ ventricular na arterial adenostne triphosphate na-achịkwa ọwa potassium nke na-akpata vasodilatation na akwara dị nro nke akwara ma na-echebe myocardium megide infarction.Obere phosphodiesterase III na-egbochi ọrụ nwere ike ọ bụghị maka nsonaazụ inotropic dị mma, lusitropic na dilating.N'adịghị ka ọgwụ cardiotonic ndị ọzọ, levosimendan nwere ike ịmepụta mmetụta inotropic dị mma na-enweghị ogologo oge ezumike myocardial ma ọ bụ ịba ụba nke arrthmias ọjọọ.E gosipụtara na ụlọ ọgwụ nwere obere ihe ize ndụ nke ịnwụ anwụ na ndị ọrịa nwere nkụda mmụọ ma e jiri ya tụnyere placebo na dobutamine.Ebe ọ bụ na o nwere ikike ka ukwuu, a na-enyocha levosimendan ugbu a dị ka ọgwụgwọ na-adịghị ala ala maka nkụda mmụọ obi.